Login

Jose M Echave

ORCID: 0009-0008-8617-5093
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5098624345
Research Areas
  • SARS-CoV-2 detection and testing
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies

Hospital Universitario Quirónsalud Madrid
 2024

 SAFETY AND IMMUNOGENICITY OF A PHH-1V BOOSTER DOSE AFTER DIFFERENT PRIME VACCINATION SCHEMES AGAINST COVID-19: PHASE III CLINICAL TRIAL FINAL RESULTS UP TO ONE YEAR
OPENALEX - Publications 
S. Martinez Rafel Ramos Jorge Navarro-Pérez Maria Jesus Lopez M. Vázquez and 17 more José Moltó Patricia Muñóz Jose M Echave José Ramón Arribas Melchor Alvarez Eunate Arana‐Arri Jordi Calls Susana Otero‐Romero Francesco Scaglione Laia Bernad Raúl Pérez‐Caballero Júlia G. Prado Ignasi Esteban Elena Aurrecoechea Roc Pomarol Montserrat Plana Álex Soriano

Abstract In this phase III, open label, single arm, multicenter clinical study, we report safety, tolerability and immunogenicity of PHH-1V as a booster dose in subjects primary vaccinated against COVID-19 with the BNT162b2, mRNA-1273, ChAdOx1-S, or Ad26.COV2.S vaccines, without previous infection. A total 2661 were included study vaccine. Most treatment-emergent adverse events (TEAE) solicited local systemic reactions grade 1 (58.70%) 2 (27.58%) intensity, being most frequently reported...

10.1101/2024.05.14.24307343 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-05-14
Coming Soon ...